Table 2. Clinical presentation of COVID-19.
| Initial clinical features | All patients (N = 100) | Haematological malignancies (n = 37) | Solid tumours (n = 44) | Paediatric patients (n = 19) |
|---|---|---|---|---|
| N (%) | n (%) | n (%) | n (%) | |
|
Initial signs and symptoms Cough Fever Dyspnoea Tachypnoea Fatigue Diarrhoea Myalgia Chest pain Anosmia Asymptomatic |
65 (65) 57 (57) 56 (56) 56 (56) 41 (41) 12 (12) 9 (9) 7 (7) 2 (2) 12 (12) |
30 (81.1) 23 (62.2) 28 (75.7) 22 (59.5) 26 (70.3) 9 (24.3) 4 (10.8) 3 (8.1) 2 (5.4) 1 (2.7) |
30 (68.2) 24 (54.5) 26 (59.1) 27 (61.4) 14 (31.8) 3 (6.8) 4 (9.1) 4 (9.1) 0 6 (13.6) |
5 (26.3) 10 (52.6) 2 (10.5) 7 (36.8) 1 (5.3) 0 1 (5.3) 0 0 5 (26.3) |
|
Severity Mild Moderate Severe Critical |
32 (32) 33 (33) 17 (17) 18 (18) |
8 (21.6) 16 (43.2) 5 (13.5) 8 (21.6) |
13 (29.5) 10 (22.7) 12 (27.3) 9 (20.5) |
11 (57.9) 7 (36.8) 0 1 (5.3) |
|
Origin of infection Community Nosocomial |
71 (71) 29 (29) |
30 (81.1) 7 (18.9) |
38 (86.4) 6 (13.6) |
3 (15.8) 16 (84.2) |
|
CT study No Yes |
11 (11) 89 (89) |
1 (2.7) 36 (97.3) |
3 (6.8) 41 (93.2) |
7 (36.8) 12 (63.2) |
|
Main finding on CT imaging Normal Consolidative Pleural effusion Nodular Ground glass |
7 (7) 29 (32) 1 (1) 3 (3) 49 (55) |
4 (11.1) 13 (36.1) 0 1 (2.8) 18 (50.0) |
0 13 (31.7) 1 (2.4) 0 27 (65.9) |
3 (25) 3 (25) 0 2 (16.7) 4 (33.3) |
| Nosocomial infections | ||||
|
Blood culturea Coagulase (−) Staphylococcus Enterobacteria Acinetobacter baumannii C. albicans Not applicable |
5 (5) 1 (1) 1 (1) 1 (1) 92 (92) |
3 (8.1) 1 (2.7) 0 0 33 (89.2) |
1 (2.3) 0 0 1 (2.3) 42 (95.5) |
1 (5.3) 0 1 (5.3) 0 17 (89.5) |
|
BAL culturea Klebsiella S. maltophilia Not done |
3 (3) 1 (1) 96 (96) |
0 1 (2.7) 36 (97.3) |
3 (6.8) 0 41 (93.2) |
0 0 19 (100.0) |
|
Urine culturea C. tropicalis Enterococcus Pseudomonas Not done |
1 (1) 1 (1) 2 (2) 96 (96) |
1 (2.7) 1 (2.7) 0 35 (94.6) |
0 0 1 (2.3) 42 (97.7) |
0 0 1 (5.3) 18 (94.7) |
a
Variables with one or more answers